MAPT and Alzheimer disease: Evandro found that NAD+ has the ability to induce mitochondrial autophagy in the AD brain and that mitochondrial autophagy inhibits the sustained increase in Aβ and tau proteins and acts as a scavenger, reversing cognitive dysfunction in APP/PS1 mice [14,15].